We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.35B
AUM Growth
-$326M
Cap. Flow
-$154M
Cap. Flow %
-4.59%
Top 10 Hldgs %
19.84%
Holding
330
New
10
Increased
53
Reduced
223
Closed
12

Top Buys

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$27.6M
2
FLYW icon
Flywire
FLYW
+$10.8M
3
WAL icon
Western Alliance Bancorporation
WAL
+$10.2M
4
PENN icon
PENN Entertainment
PENN
+$10M
5
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$9.92M

Top Sells

Rank Stock Value
1
MKTX icon
MarketAxess Holdings
MKTX
+$20.4M
2
ETSY icon
Etsy
ETSY
+$16.7M
3
U icon
Unity
U
+$16.5M
4
BKI
Black Knight, Inc. Common Stock
BKI
+$13.8M
5
AZEK
The AZEK Co
AZEK
+$11.8M

Sector Composition

Rank Sector Weight
1 Technology 23.39%
2 Healthcare 16.46%
3 Financials 15.05%
4 Consumer Discretionary 12.82%
5 Industrials 12.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
226
Sarepta Therapeutics
SRPT
$1.9B
$5.48M 0.16%
45,178
+5,166
+13% +$584K
CHRS icon
227
Coherus Oncology
CHRS
$187M
$5.16M 0.15%
1,378,567
-58,986
-4% -$272K
SILK
228
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$5.12M 0.15%
341,839
-21,235
-6% -$442K
TNDM icon
229
Tandem Diabetes Care
TNDM
$1.6B
$5.05M 0.15%
243,355
+52,897
+28% +$1.45M
RBA icon
230
RB Global
RBA
$16.1B
$5.01M 0.15%
80,160
-5,237
-6% -$323K
SYNA icon
231
Synaptics
SYNA
$4.31B
$4.99M 0.15%
55,801
-3,507
-6% -$308K
RARE icon
232
Ultragenyx Pharmaceutical
RARE
$2.59B
$4.99M 0.15%
139,870
-8,774
-6% -$348K
AKRO
233
DELISTED
Akero Therapeutics
AKRO
$4.83M 0.14%
+95,447
New +$4.44M
BLFS icon
234
BioLife Solutions
BLFS
$1.69B
$4.75M 0.14%
344,150
-21,611
-6% -$341K
TMDX icon
235
Transmedics
TMDX
$3B
$4.7M 0.14%
85,800
-24,587
-22% -$1.77M
MYGN icon
236
Myriad Genetics
MYGN
$301M
$4.5M 0.13%
280,767
-17,622
-6% -$335K
ULCC icon
237
Frontier Group Holdings
ULCC
$1.59B
$3.92M 0.12%
809,340
-34,736
-4% -$260K
LGF.B
238
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$3.92M 0.12%
497,467
-1,495,057
-75% -$11.2M
SWTX
239
DELISTED
SpringWorks Therapeutics
SWTX
$3.69M 0.11%
159,478
-10,015
-6% -$274K
CDMO
240
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$3.63M 0.11%
384,608
-23,478
-6% -$283K
VTYX
241
DELISTED
Ventyx Biosciences
VTYX
$3.28M 0.1%
94,565
-5,920
-6% -$205K
SNDX icon
242
Syndax Pharmaceuticals
SNDX
$1.84B
$3.19M 0.1%
219,974
-13,764
-6% -$260K
STKL
243
DELISTED
SunOpta
STKL
$3.17M 0.09%
940,535
+709,158
+306% +$3.55M
APPS icon
244
Digital Turbine
APPS
$1.52B
$3.09M 0.09%
510,916
-21,903
-4% -$195K
LUCK
245
Lucky Strike Entertainment
LUCK
$896M
$3.06M 0.09%
318,245
-19,920
-6% -$219K
MNRO icon
246
Monro
MNRO
$357M
$3.03M 0.09%
108,938
-6,855
-6% -$236K
ADPT icon
247
Adaptive Biotechnologies
ADPT
$3.99B
$2.4M 0.07%
439,955
-27,331
-6% -$181K
OCFC icon
248
OceanFirst Financial
OCFC
$1.84B
$2.14M 0.06%
147,748
-328,910
-69% -$5.54M
MANH icon
249
Manhattan Associates
MANH
$11B
$1.94M 0.06%
9,810
-404
-4% -$78.8K
BG icon
250
Bunge Global
BG
$21.6B
$1.48M 0.04%
13,659
-555
-4% -$60.8K
8 9
10
11 12

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Peregrine Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Peregrine Capital Management held 330 positions worth $3.35B, down 8.9% from $3.68B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Peregrine Capital Management withdrew a net $154M in Q3 2023, closing 12 positions and reducing 223 holdings. Its most notable exit was MarketAxess Holdings, an estimated $20.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Peregrine Capital Management opened a new position in DraftKings worth $27.5M.

  • Peregrine Capital Management's largest Q3 2023 buy was DraftKings: 934,591 shares worth $27.5M.
  • Peregrine Capital Management added most to Pinnacle Financial Partners Inc in Q3 2023, an estimated $9.92M increase.
  • Peregrine Capital Management's biggest Q3 2023 reduction was The AZEK Co, cutting an estimated $11.8M.
  • Peregrine Capital Management fully exited MarketAxess Holdings in Q3 2023, selling an estimated $20.4M.
  • Peregrine Capital Management's ten largest holdings make up 20% of its $3.35B portfolio in Q3 2023.
  • Peregrine Capital Management opened 10 new positions and closed 12 in Q3 2023.
  • Peregrine Capital Management's portfolio value fell 8.9% quarter-over-quarter to $3.35B.

Based on Peregrine Capital Management's 13F filing for Q3 2023, filed 19 Oct 2023.